Functional diversity of the glutathione peroxidase gene family among human populations: Implications for genetic predisposition to disease and drug response

Pharmacogenomics

Volumn 14, Issue 9, 2013, Pages 1037-1045

  Polimanti, Renato ^a   Fuciarelli, Maria ^a   Destro Bisol, Giovanni ^b   Battaggia, Cinzia ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Ethnicity; Functional prediction analysis; GPX genes; Haplotype analysis; Selenoproteins

Indexed keywords

GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE PEROXIDASE 2; GLUTATHIONE PEROXIDASE 3; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE;

ARTICLE; DISEASE PREDISPOSITION; DRUG RESPONSE; ETHNIC DIFFERENCE; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GLUTATHIONE PEROXIDASE 1 GENE; GLUTATHIONE PEROXIDASE 2 GENE; GLUTATHIONE PEROXIDASE 3 GENE; GLUTATHIONE PEROXIDASE 5 GENE; GLUTATHIONE PEROXIDASE 6 GENE; GLUTATHIONE PEROXIDASE 7 GENE; GLUTATHIONE PEROXIDASE 8 GENE; GLUTATHIONE PEROXIDASE GENE; HAPLOTYPE; HUMAN; NATURAL SELECTION; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE GENE; PREDICTION;

ANTIOXIDANTS; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS, PHARMACOLOGICAL; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GLUTATHIONE PEROXIDASE; HAPLOTYPES; HUMAN GENOME PROJECT; HUMANS; OXIDATION-REDUCTION; POLYMORPHISM, GENETIC; POPULATION;

EID: 84880476025     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.13.99     Document Type: Article

References (49)

1. Polimanti R, Piacentini S, Fuciarelli M. HapMap-based study of human soluble glutathione S-transferase enzymes: The role of natural selection in shaping the single nucleotide polymorphism diversity of xenobiotic-metabolizing genes. Pharmacogenet. Genomics 21(10), 665-672 (2011).
2. Polimanti R, Piacentini S, Manfellotto D, Fuciarelli M. Human genetic variation of CYP450 superfamily: Analysis of functional diversity in worldwide populations. Pharmacogenomics 13(16), 1951-1960 (2012).
3. International Hapmap 3 Consortium, Altshuler DM, Gibbs RA et al. Integrating common and rare genetic variation in diverse human populations. Nature 467(7311), 52-58 (2010).
4. Li JZ, Absher DM, Tang H et al. Worldwide human relationships inferred from genome-wide patterns of variation. Science 319(5866), 1100-1104 (2008).
5. 1000 Genomes Project Consortium, Abecasis GR, Altshuler D et al. A map of human genome variation from population-scale sequencing. Nature 467(7319), 1061-1073 (2010).
6. Doss CG. In silico profiling of deleterious amino acid substitutions of potential pathological importance in haemophlia A and haemophlia B. J. Biomed. Sci. 19, 30 (2012).
7. Thomas JH. Rapid birth-death evolution specific to xenobiotic cytochrome P450 genes in vertebrates. PLoS Genet. 3(5), e67 (2007).
8. Fuselli S, de Filippo C, Mona S et al. Evolution of detoxifying systems: The role of environment and population history in shaping genetic diversity at human CYP2D6 locus. Pharmacogenet. Genomics 20(8), 485-499 (2010).
9. Tomalik-Scharte D, Lazar A, Fuhr U, Kirchheiner J. The clinical role of genetic polymorphisms in drug-metabolizing enzymes. Pharmacogenomics J. 8(1), 4-15 (2008).
10. Bolt HM, Hengstler JG. A new series of review articles on drug metabolizing enzymes: Nomenclature of isoenzyme families, genetic organization, polymorphisms, substrate specificities, clinical relevance and role in carcinogenesis. Arch. Toxicol. 82(7), 413-414 (2008).
11. Brigelius-Flohe R, Maiorino M. Glutathione peroxidases. Biochim. Biophys. Acta 1830(5), 3289-3303 (2012).
12. Lubos E, Loscalzo J, Handy DE. Glutathione peroxidase-1 in health and disease: From molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 15(7), 1957-1997 (2011).
13. Yuzhalin AE, Kutikhin AG. Inherited variations in the SOD and GPX gene families and cancer risk. Free Radic. Res. 46(5), 581-599 (2012).
14. Ferguson LR, Karunasinghe N, Zhu S, Wang AH. Selenium and its' role in the maintenance of genomic stability. Mutat. Res. 733(1-2), 100-110 (2012).
15. Iida R, Tsubota E, Yuasa I, Takeshita H, Yasuda T. Simultaneous genotyping of 11 non-synonymous SNPs in the 4 glutathione peroxidase genes using the multiplex single base extension method. Clin. Chim. Acta 402(1-2), 79-82 (2009).
16. Takata Y, King IB, Lampe JW et al. Genetic variation in GPX1 is associated with GPX1 activity in a comprehensive analysis of genetic variations in selenoenzyme genes and their activity and oxidative stress in humans. J. Nutr. 142(3), 419-426 (2012).
17. Nowak-Gottl U, Fiedler B, Huge A et al. Plasma glutathione peroxidase in pediatric stroke families. J. Thromb. Haemost. 9(1), 33-38 (2011).
18. Vieira SM, Monteiro MB, Marques T et al. Association of genetic variants in the promoter region of genes encoding p22phox (CYBA) and glutamate cysteine ligase catalytic subunit (GCLC) and renal disease in patients with type 1 diabetes mellitus. BMC Med. Genet. 12, 129 (2011).
19. Steinbrecher A, Meplan C, Hesketh J et al. Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men. Cancer Epidemiol. Biomarkers Prev. 19(11), 2958-2968 (2010).
20. Polonikov AV, Vialykh EK, Churnosov MI et al. The C718T polymorphism in the 3′-untranslated region of glutathione peroxidase-4 gene is a predictor of cerebral stroke in patients with essential hypertension. Hypertens. Res. 35(5), 507-512 (2012).
21. Li Y, Sun Z, Cunningham JM et al. Genetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung cancer treated with chemotherapy. Clin. Cancer Res. 17(11), 3830-3840 (2011).
22. Chowdhury S, Hobbs CA, MacLeod SL et al. Associations between maternal genotypes and metabolites implicated in congenital heart defects. Mol. Genet. Metab. 107(3), 596-604 (2012).
23. Kim JC, Lee HC, Cho DH et al. Genome-wide identification of possible methylation markers chemosensitive to targeted regimens in colorectal cancers. J. Cancer Res. Clin. Oncol. 137(10), 1571-1580 (2011).
24. Maitland ML, Grimsley C, Kuttab-Boulos H et al. Comparative genomics analysis of human sequence variation in the UGT1A gene cluster. Pharmacogenomics J. 6(1), 52-62 (2006).
25. 1000 Genomes Project Consortium, Abecasis GR, Auton A et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491(7422), 56-65 (2012).
26. Davydov EV, Goode DL, Sirota M, Cooper GM, Sidow A, Batzoglou S. Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comput. Biol. 6(12), e1001025 (2010).
27. Adzhubei IA, Schmidt S, Peshkin L et al. A method and server for predicting damaging missense mutations. Nat. Methods 7(4), 248-249 (2010).
28. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4(7), 1073-1081 (2009).
29. Thomas PD, Kejariwal A. Coding single-nucleotide polymorphisms associated with complex vs. Mendelian disease: Evolutionary evidence for differences in molecular effects. Proc. Natl Acad. Sci. USA 101(43), 15398-15403 (2004).
30. Brunham LR, Singaraja RR, Pape TD, Kejariwal A, Thomas PD, Hayden MR. Accurate prediction of the functional significance of single nucleotide polymorphisms and mutations in the ABCA1 gene. PLoS Genet. 1(6), e83 (2005).
31. Grillo G, Turi A, Licciulli F et al. UTRdb and UTRsite (RELEASE 2010): A collection of sequences and regulatory motifs of the untranslated regions of eukaryotic mRNAs. Nucleic Acids Res. 38(Database issue), D75-D80 (2010).
32. Excoffier L, Lischer HE. Arlequin suite ver 3.5: A new series of programs to perform population genetics analyses under Linux and Windows. Mol. Ecol. Resour. 10(3), 564-567 (2010).
33. Hofer T, Ray N, Wegmann D, Excoffier L. Large allele frequency differences between human continental groups are more likely to have occurred by drift during range expansions than by selection. Ann. Hum. Genet. 73(1), 95-108 (2009).
34. Voight BF, Kudaravalli S, Wen X, Pritchard JK. A map of recent positive selection in the human genome. PLoS Biol. 4(3), e72 (2006).
35. Matise TC, Chen F, Chen W et al. A second-generation combined linkage physical map of the human genome. Genome Res. 17(12), 1783-1786 (2007).
36. Marian AJ. Molecular genetic studies of complex phenotypes. Transl. Res. 159(2), 64-79 (2012).
37. Squitti R, Polimanti R. Copper hypothesis in the missing hereditability of sporadic Alzheimer's disease: ATP7B gene as potential harbor of rare variants. J. Alzheimers Dis. 29(3), 493-501 (2012).
38. Nelson MR, Wegmann D, Ehm MG et al. An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people. Science 337(6090), 100-104 (2012).
39. Ingram CJ, Raga TO, Tarekegn A et al. Multiple rare variants as a cause of a common phenotype: Several different lactase persistence associated alleles in a single ethnic group. J. Mol. Evol. 69(6), 579-588 (2009).
40. Lee Y, Gamazon ER, Rebman E et al. Variants affecting exon skipping contribute to complex traits. PLoS Genet. 8(10), e1002998 (2012).
41. Foster CB, Aswath K, Chanock SJ, McKay HF, Peters U. Polymorphism analysis of six selenoprotein genes: Support for a selective sweep at the glutathione peroxidase 1 locus (3p21) in Asian populations. BMC Genet. 7, 56 (2006).
42. Suo C, Xu H, Khor CC et al. Natural positive selection and north-south genetic diversity in east Asia. Eur. J. Human Genet. 20(1), 102-110 (2012).
43. Najafi M, Ghasemi H, Roustazadeh A, Alipoor B. Phenotype and genotype relationship of glutathione peroxidase1 (GPx1) and rs 1800668 variant: The homozygote effect on kinetic parameters. Gene 505(1), 19-22 (2012).
44. Thorn CF, Oshiro C, Marsh S et al. Doxorubicin pathways: Pharmacodynamics and adverse effects. Pharmacogenet. Genomics 21(7), 440-446 (2011).
45. Chen B, Rao X, House MG, Nephew KP, Cullen KJ, Guo Z. GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy response. Cancer Lett. 309(1), 37-45 (2011).
46. Takebe G, Yarimizu J, Saito Y et al. A comparative study on the hydroperoxide and thiol specificity of the glutathione peroxidase family and selenoprotein P. J. Biol. Chem. 277(43), 41254-41258 (2002).
47. Maiorino M, Ursini F, Bosello V et al. The thioredoxin specificity of Drosophila GPx: A paradigm for a peroxiredoxin-like mechanism of many glutathione peroxidases. J. Mol. Biol. 365(4), 1033-1046 (2007).
48. Olson GE, Whitin JC, Hill KE et al. Extracellular glutathione peroxidase (Gpx3) binds specifically to basement membranes of mouse renal cortex tubule cells. Am. J. Physiol. Renal. Physiol. 298(5), F1244-F1253 (2010).
49. Jin RC, Mahoney CE, Coleman Anderson L et al. Glutathione peroxidase-3 deficiency promotes platelet-dependent thrombosis in vivo. Circulation 123(18), 1963-1973 (2011).